Delivery Order SPE2DB20D1109-SPE2DB23FN34B
Award Date 1/13/23
Potential Completion Date 1/17/23
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which has been awarded a contract to supply a variety of prescription medications, over-the-counter drugs, and medical supplies to support military treatment programs and facilities worldwide. The specific item being delivered under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,560,258,236 units of PROLENSA 0.07% eye drops. The Firm Fixed Price delivery order, valued at $4,319.98, has a period of performance through March 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,555,355,594 units of PROLENSA 0.07% eye drops in 3 milliliter vials. The firm-fixed-price delivery order, valued at $16,328.27, has a period of performance through November 9, 2021. This award is not designated as a set-aside contract. The contract is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,015.00, is for the delivery of Prolensa 0.07% eye drops, a prescription medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through August 2024. The IDC enables the DLA to efficiently procure essential pharmaceutical products to...
- This federal contract award, valued at $2,564.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLENSA 0.07% eye drops with an ultimate completion date of January 28, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,379.85 Firm Fixed Price Delivery Order is for the supply of Prolensa 0.07% eye drops, a specialty pharmaceutical product, with a completion date of October 30, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, identified as SPE2DB20D3505|SPE2DB25FT9X0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,588.91, is a Firm Fixed Price Delivery Order for the supply of PROLENSA 0.07% eye drops. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of PROLENSA 0.07% eye drops in a 3mL size, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $31,080.95, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to the Department of Defense (DoD) and Department of Veterans...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Prolensa 0.07% eye drops (3 ml). The contract has a ceiling value of $6,433.85 and a completion date of September 22, 2023. AmerisourceBergen is a major pharmaceutical distributor that specializes in providing medical products and supplies to federal agencies, including the military and veterans' healthcare systems. This award is part of AmerisourceBergen's...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of PROLENSA 0.07% eye drops, a prescription pharmaceutical product, with a ceiling value of $1,079.55 and an ultimate completion date of August 1, 2024. The contract does not have a set-aside designation. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal...